Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

ICC International Cannabis Corp WLDCF

ICC International Cannabis Corp is a Canadian company which is engaged in planning, designing, building and operating cannabis production, processing, and distribution facilities worldwide. The company through its holdings is engaged in the pharmaceutical distribution, wholesale importation, research, and development, as well as working interests in industrial hemp licenses in Greece, licenses to cultivate, produce, distribute, store, and export Cannabis and Cannabis derivatives in Colombia, the


OTCPK:WLDCF - Post by User

Comment by HiGhRoLLeR420on Mar 12, 2018 5:07pm
108 Views
Post# 27703179

RE:RE:RE:March.12.18 interview with CEO - MUST READ

RE:RE:RE:March.12.18 interview with CEO - MUST READNo worries for you Johnn. No worries for anyone who has made a purchase. I wish I could buy more!

The following was copied from the translated interview. The highlighted portions are the most important part!:

The big players from Canada make no secret of their plans for expansion to South America, and ICC Labs may soon be in their sights as many may now thinkThis offers intelligent investors a profit potential of almost 400 percent. 

We see the price target for ICC Labs Inc. (WKN: A2JAMF ) at 6-50 months at 4.50 euros. GMP Securities analysts in their recent update estimate that ICC Labs could deliver tremendous earnings momentum. According to the experts, ICC Labs could generate more than $ 450 million in revenue and earnings before interest, taxes, depreciation and amortization (EBITDA) of approximately $ 150 million a year. Given the industry-standard valuation (6-8x EBITDA), ICC Labs could justify a valuation of $ 7.00 per share, analysts said. 

In the coming weeks and months we expect a strong news flow. According to the company, ICC Labs intends, among other things, to enter the field of cannabis research by cooperating with one of the most renowned research institutions in the world. 

In addition, we expect the signing of further international export agreements in North America, Latin America and Europe, the first large field harvest, the completion of the CBD extraction plant and the start of business activities in Colombia.




Happy Investing!


<< Previous
Bullboard Posts
Next >>